Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vita Coco Company (COCO) Cash & Equivalents (2020 - 2026)

Vita Coco Company (COCO) has disclosed Cash & Equivalents for 7 consecutive years, with $201.9 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 31.45% year-over-year to $201.9 million; the TTM value through Mar 2026 reached $201.9 million, up 31.45%, while the annual FY2025 figure was $196.9 million, 19.56% up from the prior year.
  • Cash & Equivalents hit $201.9 million in Q1 2026 for Vita Coco Company, up from $196.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $203.7 million in Q3 2025 and bottomed at $16.4 million in Q2 2022.
  • Average Cash & Equivalents over 5 years is $111.6 million, with a median of $132.5 million recorded in 2023.
  • Year-over-year, Cash & Equivalents plummeted 40.93% in 2022 and then skyrocketed 575.21% in 2023.
  • Vita Coco Company's Cash & Equivalents stood at $19.6 million in 2022, then surged by 575.21% to $132.5 million in 2023, then grew by 24.24% to $164.7 million in 2024, then rose by 19.56% to $196.9 million in 2025, then increased by 2.56% to $201.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $201.9 million, $196.9 million, and $203.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.